Powder: -20°C for 3 years | In solvent: -80°C for 1 year
(R)-Lisofylline ((R)-Lisophylline) is an inhibitor of lysophosphatidic acid acyltransferase (IC50 = 0.6 µM). (R)-Lisofylline interrupts IL-12 signaling-mediated STAT4 activation and can be used in studies about the treatment of type 1 diabetes and autoimmune disorders.
パッケージサイズ | 在庫状況 | 単価(税別) | |
---|---|---|---|
1 mg | 在庫あり | ¥ 52,000 | |
5 mg | 在庫あり | ¥ 132,000 | |
10 mg | 在庫あり | お問い合わせ | |
50 mg | 在庫あり | お問い合わせ | |
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 119,000 |
説明 | (R)-Lisofylline ((R)-Lisophylline) is an inhibitor of lysophosphatidic acid acyltransferase (IC50 = 0.6 µM). (R)-Lisofylline interrupts IL-12 signaling-mediated STAT4 activation and can be used in studies about the treatment of type 1 diabetes and autoimmune disorders. |
別名 | (R)-Lisophylline |
分子量 | 280.32 |
分子式 | C13H20N4O3 |
CAS No. | 100324-81-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45 mg/mL (160.53 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
(R)-Lisofylline 100324-81-0 JAK/STAT signaling Stem Cells STAT (R)-Lisophylline Pentoxifylline Inhibitor anti-inflammatory inhibit STAT4 lysophosphatidic (R)Lisofylline acid IL-12 IFN-γ diabetes immunomodulator Lisofylline (R) Lisofylline acyltransferase LPS metabolite Lisophylline inhibitor